SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Bill Wexler's Dog Pound
REFR 1.847-1.2%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bradpalm1 who wrote (2707)8/1/1999 5:23:00 PM
From: out_of_the_loop  Read Replies (1) of 10293
 
GUMM proponents generally believe that the NEJM studies will be printed but we are not pinning all our hopes on it. In the near term we are concentrating on the fact that Zicam will be in over 40,000 stores for this cold season.

The rhinovirus has many serotypes and they are indeed not the only cause of the common cold, just the majority of cases. If I had a cold and I knew that most of the cases were caused by viruses attacking by this mechanism, and I could likely get rid of it by using Zicam, I would spend the $10 or so to find out. We think other people will, too. If it doesn't work for the majority of people, the stock will not do well. If it does, it will.

The blockage of the ICAM has been proven as the pathogenesis of such viruses. That is why Tremacamra (a soluble intercellular adhesion molecule made by recombinant methods) works. JAMA. 1999;281:1797-1804.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext